Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
lisinopril	O
/	O
diltiazem	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Symptomatic	O
bradycardia	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Coronary	O
artery	O
angiography	O
___:	O
Drug	O
eluting	O
stent	O
of	O
mid-RCA	O
and	O
drug	O
eluting	O
stent	O
of	O
proximal	O
and	O
ostial	O
RCA	O
with	O
overlapping	O
drug	O
eluting	O
stents	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
an	O
___	O
___-speaking	O
female	O
HTN,	O
HLD,	O
DM2,	O
right	O
dominant	O
3VD	O
CAD	O
who	O
was	O
recently	O
admitted	O
for	O
UA	O
after	O
being	O
asymptomatic	O
since	O
___	O
PCI	O
to	O
___	O
and	O
had	O
DES	O
to	O
mid-LAD	O
who	O
now	O
presents	O
with	O
symptoms	O
of	O
pre-syncope,	O
nausea/vomiting	O
x	O
___	O
days	O
and	O
found	O
to	O
have	O
new	O
bradycardia.	O
Not	O
a	O
CABG	O
candidate	O
for	O
3VD	O
because	O
___'s	O
Witness.	O
___	O
PCI	O
showed	O
right	O
dominant	O
with	O
patent	O
stents	O
to	O
LCx,	O
90%	O
mid	O
LAD	O
(DES),	O
long	O
60%	O
mid	O
calcified,	O
60%	O
first	O
diagonal,	O
and	O
RCA	O
with	O
70%	O
ostial	O
and	O
80%	O
mid	O
stenoses.	O
TTE	O
showed	O
normal	O
biventricular	O
function.	O
She	O
was	O
discharged	O
home	O
on	O
___	O
with	O
___,	O
metoprolol	O
as	O
well	O
as	O
diltiazem,	O
which	O
was	O
started	O
for	O
angina.	O
In	O
the	O
past	O
___	O
days	O
she	O
has	O
been	O
feeling	O
weak,	O
"heavy",	O
lightheaded,	O
and	O
nauseated,	O
which	O
worsened	O
___,	O
culminating	O
in	O
2	O
episodes	O
of	O
non-blood	B-Upper_gastrointestinal_haemorrhage
emesis	B-Upper_gastrointestinal_haemorrhage
for	O
which	O
she	O
went	O
to	O
___	O
___	O
where	O
she	O
was	O
found	O
to	O
be	O
bradycardic.	O
Head	O
CT	O
and	O
CXR	O
were	O
unremarkable	O
there.	O
She	O
admits	O
to	O
daily	O
chest	O
pain	O
with	O
minimal	O
activity	O
(relieved	O
by	O
SLNG)	O
since	O
discharge,	O
but	O
denies	O
orthopnea,	O
pedal	O
edema,	O
palpitations,	O
febrile	O
illness,	O
cough.	O
She	O
denies	O
diarrhea,	O
fever,	O
or	O
abnormal	O
ingestion.	O
Her	O
last	O
BM	O
was	O
yesterday	O
morning	O
and	O
was	O
normal.	O
She	O
has	O
had	O
reduced	O
appetite,	O
but	O
has	O
been	O
urinating	O
more	O
than	O
normal.	O
Her	O
blood	O
sugars	O
have	O
been	O
150s	O
in	O
the	O
AM	O
and	O
she	O
did	O
not	O
miss	O
insulin	O
doses.	O
Her	O
pharmacy	O
bubble	O
packs	O
meds	O
and	O
her	O
___	O
is	O
still	O
coming.	O
Notably,	O
her	O
husband	O
had	O
emesis/diarrhea	O
several	O
days	O
ago	O
that	O
lasted	O
1	O
day.	O
In	O
the	O
ED,	O
initial	O
vitals	O
were:	O
97.2	O
44	O
126/55	O
16	O
100%	O
RA	O
EKG	O
sinus	O
bradycardia	O
to	O
39,	O
long	O
qtc	O
>550	O
Labs	O
in	O
the	O
ED	O
were	O
notable	O
for	O
K	O
6.7	O
>	O
6.1,	O
creatinine	O
of	O
1.0,	O
lactate	O
of	O
2.7.	O
In	O
the	O
ED	O
pt	O
received	O
aspirin,	O
Ca	O
gluconate,	O
and	O
insulin	O
for	O
hyperkalemia.	O
Vitals	O
prior	O
to	O
transfer	O
were:	O
HR	O
44	O
BP	O
108/56	O
RR	O
18	O
Sa02	O
98%	O
NC	O
Upon	O
arrival	O
to	O
the	O
floor,	O
HR	O
42-52,	O
sBP	O
120.	O
Looking	O
comfortable.	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS:	O
+Diabetes,	O
+Dyslipidemia,	O
+Hypertension	O
2.	O
CARDIAC	O
HISTORY:	O
-	O
CABG:	O
none	O
-	O
PERCUTANEOUS	O
CORONARY	O
INTERVENTIONS:	O
___:	O
DES	O
of	O
proximal	O
and	O
distal	O
circumflex	O
lesions.	O
-	O
PACING/ICD:	O
none	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY:	O
Iron	O
deficiency	O
anemia	O
Vitamin	O
B	O
deficiency	O
Osteoarthritis	O
Asthma	O
Right	O
carotid	O
artery	O
stenosis	O
Chronic	O
open	O
angle	O
glaucoma	B-Visual_impairment
Cataract	B-Visual_impairment
left	O
eye	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
and	O
mother	O
deceased	O
in	O
___	O
-	O
unknown	O
cause.	O
1	O
brother	O
alive	O
in	O
___	O
without	O
CAD.	O
1	O
sister	O
with	O
CAD	O
in	O
___.	O
Multiple	O
siblings	O
deceased.	O
Physical	O
Exam:	O
ADMISSION	O
EXAM	O
--------------	O
VS:	O
T=36.4	O
BP=120/43	O
HR=45	O
RR=22	O
O2	O
sat=	O
100%	O
___:	O
elderly	O
woman	O
lying	O
in	O
bed	O
in	O
NAD	O
HEENT:	O
anicteric	O
sclerae,	O
cloudy	O
lenses	O
bilaterally,	O
dry	O
mouth	O
Neck:	O
no	O
JVD	O
CV:	O
regular,	O
bradycardic,	O
Lungs:	O
clear	O
Abdomen:	O
soft,	O
nt,	O
nd	O
GU:	O
no	O
foley	O
Ext:	O
warm,	O
2+	O
DP	O
pulses,	O
no	O
edema	O
Neuro:	O
alert	O
to	O
hospital,	O
date,	O
situation.	O
CN2-12	O
intact.	O
Skin:	O
no	O
skin	O
defects	O
DISCHARGE	O
EXAM	O
--------------	O
98.8/98.7,	O
BP	O
133-158/54-62	O
HR	O
___	O
RR	O
18,	O
O2	O
sat	O
98%	O
RA.	O
Weight	O
75.1k	O
(75.5k)	O
I/O:	O
24h:	O
1680/450	O
8h:	O
60/1010	O
Tele:	O
___	O
SR	O
.	O
Neuro:	O
A/O	B-Delirium
x3.	B-Delirium
Unable	O
to	O
fully	O
assess	O
___	O
language	O
barrier	O
Lungs	O
CTA	O
CV:	O
RRR<	O
Normal	O
S1,	O
S2.	O
GI:	O
+	O
BS,	O
NPO.	O
GU:	O
Voiding	O
VASC:	O
Distal	O
DP's,	O
___	O
palpable.	O
Right	O
great	O
toe	O
with	O
crack	O
at	O
MCP	O
joint	O
on	O
plantar	O
aspect,	O
has	O
bacitracin	O
on	O
and	O
tender.	O
Right	O
groin	O
site	O
without	O
bruit	O
or	O
hematoma.	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
--------------	O
___	O
11:05PM	O
BLOOD	O
WBC-6.5	O
RBC-3.40*	O
Hgb-11.5*	O
Hct-35.4*	O
MCV-104*	O
MCH-33.8*	O
MCHC-32.5	O
RDW-12.1	O
Plt	O
___	O
___	O
11:05PM	O
BLOOD	O
Neuts-82.7*	O
Lymphs-12.5*	O
Monos-4.0	O
Eos-0.7	O
Baso-0.2	O
___	O
11:05PM	O
BLOOD	O
___	O
PTT-31.1	O
___	O
___	O
11:05PM	O
BLOOD	O
Glucose-211*	O
UreaN-14	O
Creat-1.0	O
Na-135	O
K-6.7*	O
Cl-101	O
HCO3-22	O
AnGap-19	O
___	O
11:05PM	O
BLOOD	O
Albumin-4.2	O
___	O
05:37AM	O
BLOOD	O
Calcium-9.0	O
Phos-3.5	O
Mg-2.3	O
PERTINENT	O
LABS	O
--------------	O
___	O
11:05PM	O
BLOOD	O
CK-MB-1	O
___	O
11:05PM	O
BLOOD	O
cTropnT-<0.01	O
___	O
05:37AM	O
BLOOD	O
cTropnT-<0.01	O
___	O
08:00AM	O
BLOOD	O
cTropnT-<0.01	O
___	O
12:15PM	O
BLOOD	O
cTropnT-<0.01	O
___	O
11:05PM	O
BLOOD	O
Lipase-31	O
REPORTS:	O
--------	O
CARDIAC	O
CATH:	O
Findings	O
ESTIMATED	O
blood	O
loss:	O
5	O
cc	O
Hemodynamics	O
(see	O
above):	O
Coronary	O
angiography:	O
right	O
dominant	O
LMCA:	O
LAD:	O
patent	O
stents	O
LCX:	O
patent	O
stents	O
RCA:	O
70%	O
ostial,	O
long	O
90%	O
mid	O
Interventional	O
details	O
Change	O
for	O
___	O
guide	O
and	O
ultimately	O
successful	O
with	O
AL.75	O
guide.	O
Drug	O
eluting	O
stent	O
of	O
mid	O
RCA	O
with	O
2.5	O
by	O
28	O
Promus	O
Premier	O
and	O
drug	O
eluting	O
stent	O
of	O
proximal	O
and	O
ostial	O
RCA	O
with	O
overlapping	O
2.75	O
by	O
32	O
Promus	O
Premier	O
both	O
postdilated	O
to	O
2.75	O
mm	O
at	O
high	O
pressures	O
with	O
good	O
result.	O
Angiomax	O
used.	O
Angioseal	O
right	O
femoral	O
artery.	O
DISCHARGE	O
LABS	O
--------------	O
___	O
07:35AM	O
BLOOD	O
WBC-5.5	O
RBC-3.78*	O
Hgb-12.5	O
Hct-39.9	O
MCV-106*	O
MCH-33.1*	O
MCHC-31.3	O
RDW-12.5	O
Plt	O
___	O
___	O
07:35AM	O
BLOOD	O
Glucose-148*	O
UreaN-11	O
Creat-0.9	O
Na-139	O
K-3.8	O
Cl-104	O
HCO3-24	O
AnGap-15	O
___	O
07:35AM	O
BLOOD	O
Calcium-9.6	O
Phos-3.4	O
Mg-2.___SSESSMENT	O
AND	O
PLAN:	O
___	O
Jehova's	O
Witness	O
with	O
3VD	O
CAD,	O
DMII,	O
HTN,	O
HLD	O
who	O
presents	O
from	O
home	O
with	O
___	O
days	O
of	O
presyncope,	O
emesis	O
and	O
found	O
to	O
have	O
bradycardia	O
to	O
___	O
likely	O
due	O
to	O
medications.	O
#	O
CAD:	O
s/p	O
DES	O
to	O
proximal	O
and	O
distal	O
circumflex	O
lesions	O
in	O
___.	O
She	O
underwent	O
cardiac	O
cath	O
on	O
___	O
for	O
unstable	O
angina	O
with	O
DES	O
to	O
LAD.	O
At	O
that	O
time,	O
the	O
high-grade	O
RCA	O
stenosis	O
was	O
not	O
treated	O
as	O
it	O
unclear	O
whether	O
it	O
was	O
suitable	O
for	O
PCI.	O
She	O
was	O
discharged	O
in	O
___	O
with	O
3	O
vessel	O
CAD	O
and	O
difficult	O
to	O
control	O
angina	O
despite	O
LAD	O
PCI.	O
She	O
was	O
not	O
thought	O
to	O
be	O
a	O
candidate	O
for	O
CABG	O
because	O
she	O
is	O
a	O
Jehova's	O
Witness.	O
She	O
was	O
started	O
on	O
diltiazem	O
120mg	O
CR	O
in	O
addition	O
to	O
metoprolol	O
XL	O
100mg,	O
ranolazine	O
1000mg	O
BID,	O
and	O
isosorbide	O
mononitrate	O
150mg	O
daily	O
in	O
___	O
because	O
she	O
had	O
ongoing	O
angina.	O
This	O
admission,	O
her	O
diltiazem	O
was	O
held	O
given	O
marked	O
bradycardia	O
and	O
amlodipine	O
was	O
started	O
for	O
anginal	O
control.	O
She	O
had	O
coronary	O
angiography	O
showing	O
patent	O
LCx	O
and	O
LAD	O
stents.	O
She	O
underwent	O
high-risk	O
PCI	O
to	O
RCA	O
territory	O
with	O
DES	O
to	O
mid-RCA	O
and	O
DES	O
to	O
proximal	O
and	O
ostial	O
RCA.	O
She	O
was	O
continued	O
on	O
aspirin,	O
clopidogrel,	O
atorvastatin,	O
ranolazine,	O
isosorbide	O
mononitrate,	O
metoprolol	O
succinate,	O
and	O
amlodipine	O
was	O
started	O
to	O
replace	O
diltiazem	O
in	O
an	O
effort	O
to	O
reduce	O
myocardial	O
oxygen	O
demand.	O
Medications	O
were	O
maximized	O
(See	O
discharge	O
meds)	O
#	O
Sinus	O
bradycardia:	O
Patient	O
presented	O
with	O
bradycardia	O
that	O
was	O
junctional	O
alternating	O
with	O
sinus	O
in	O
the	O
___	O
with	O
presyncope	O
in	O
the	O
setting	O
of	O
mild	O
hypovolemia	O
due	O
to	O
prior	O
emesis.	O
Her	O
home	O
AV	O
nodal	O
blockers	O
(diltiazem	O
120	O
mg	O
CR	O
&	O
metoprolol	O
succinate	O
100	O
mg)	O
were	O
held,	O
and	O
were	O
suspected	O
to	O
be	O
the	O
cause	O
of	O
her	O
bradycaria.	O
When	O
her	O
heart	O
rate	O
improved	O
to	O
the	O
___	O
her	O
metoprolol	O
was	O
restarted	O
at	O
a	O
lower	O
dose.	O
Diltiazem	O
was	O
not	O
restarted.	O
It	O
was	O
originally	O
prescribed	O
for	O
refractory	O
angina	O
despite	O
maximal	O
medical	O
therapy	O
in	O
the	O
setting	O
of	O
known	O
3VD	O
with	O
RCA	O
territory	O
that	O
was	O
not	O
previously	O
intervened	O
upon	O
given	O
complexity	O
of	O
PCI.	O
She	O
was	O
started	O
on	O
amlodipine	O
to	O
replace	O
diltiazem.	O
#	O
Presyncope:	O
Low	O
cardiac	O
output	O
either	O
related	O
to	O
depressed	O
HR	O
or	O
to	O
depressed	O
SV	O
(from	O
hypovolemia	O
secondary	O
to	O
emesis).	O
Labs	O
showed	O
improved	O
Cr	O
after	O
1L	O
IVF,	O
suggesting	O
likely	O
hypovolemic	O
component	O
exacerbating	O
her	O
bradycardia	O
and	O
contributing	O
to	O
presyncope.	O
#	O
DMII:	O
Held	O
home	O
metformin.	O
Continue	O
home	O
glargine	O
20	O
units	O
qHS	O
and	O
HISS	O
#	O
Glaucoma:	B-Visual_impairment
Continued	O
on	O
home	O
latanoprost	O
#	O
Anemia:	O
Unchanged	O
H&H	O
since	O
last	O
admission.	O
Continued	O
B12,	O
FeSO4	O
TRANSITIONAL	O
ISSUES:	O
[	O
]	O
consider	O
ACE	O
as	O
outpatient,	O
held	O
this	O
admit	O
in	O
setting	O
of	O
hyperkalemia	O
(to	O
6.7)	O
on	O
admit.	O
[	O
]	O
med	O
change:	O
pt's	O
amlodipine	O
replaced	O
diltiazem	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Acetaminophen	O
500	O
mg	O
PO	O
Q6H:PRN	O
pain	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
80	O
mg	O
PO	O
DAILY	O
4.	O
Bacitracin/Polymyxin	O
B	O
Sulfate	O
Opht.	O
Oint	O
1	O
Appl	O
RIGHT	O
EYE	O
HS	O
5.	O
Cetirizine	O
10	O
mg	O
oral	O
daily	O
6.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
7.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
8.	O
Ferrous	O
GLUCONATE	O
324	O
mg	O
PO	O
TID	O
9.	O
Fluticasone	O
Propionate	O
NASAL	O
3	O
SPRY	O
NU	O
DAILY	O
10.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
120	O
mg	O
PO	O
DAILY	O
11.	O
Latanoprost	O
0.005%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
HS	O
12.	O
ranolazine	O
1,000	O
mg	O
oral	O
BID	O
13.	O
Diltiazem	O
Extended-Release	O
120	O
mg	O
PO	O
HS	O
14.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
15.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
PRN	O
Chest	O
pain	O
16.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q4H:PRN	O
shortness	O
of	O
breath	O
17.	O
MetFORMIN	O
(Glucophage)	O
250	O
mg	O
PO	O
BID	O
18.	O
Meclizine	O
25	O
mg	O
PO	O
Q12H:PRN	O
vertigo	O
19.	O
Glargine	O
20	O
Units	O
Bedtime	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
500	O
mg	O
PO	O
Q6H:PRN	O
pain	O
2.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q4H:PRN	O
shortness	O
of	O
breath	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Atorvastatin	O
80	O
mg	O
PO	O
DAILY	O
5.	O
Bacitracin/Polymyxin	O
B	O
Sulfate	O
Opht.	O
Oint	O
1	O
Appl	O
RIGHT	O
EYE	O
HS	O
6.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
7.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
8.	O
Ferrous	O
GLUCONATE	O
324	O
mg	O
PO	O
TID	O
9.	O
Fluticasone	O
Propionate	O
NASAL	O
3	O
SPRY	O
NU	O
DAILY	O
10.	O
Glargine	O
20	O
Units	O
Bedtime	O
11.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
180	O
mg	O
PO	O
DAILY	O
RX	O
*isosorbide	O
mononitrate	O
60	O
mg	O
3	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*90	O
Tablet	O
Refills:*3	O
12.	O
Latanoprost	O
0.005%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
HS	O
13.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
PRN	O
Chest	O
pain	O
14.	O
ranolazine	O
1,000	O
mg	O
oral	O
BID	O
15.	O
Amlodipine	O
10	O
mg	O
PO	O
DAILY	O
RX	O
*amlodipine	O
10	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*3	O
16.	O
MetFORMIN	O
(Glucophage)	O
250	O
mg	O
PO	O
BID	O
17.	O
Meclizine	O
25	O
mg	O
PO	O
Q12H:PRN	O
vertigo	O
18.	O
Cetirizine	O
10	O
mg	O
oral	O
daily	O
19.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
RX	O
*metoprolol	O
succinate	O
50	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*3	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Lives_in_carehome
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Angina	O
Coronary	O
artery	O
disease	O
Sinus	O
and	O
junctional	O
bradycaria	O
Superficial	O
foot	O
laceration	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Ms.	O
___,	O
you	O
were	O
admitted	O
to	O
___	O
for	O
a	O
very	O
slow	O
heart	O
rate	O
(bradycardia).	O
We	O
think	O
your	O
heart	O
rate	O
was	O
slow	O
because	O
of	O
medications	O
(metoprolol	O
and	O
diltiazem).	O
We	O
lowered	O
your	O
doses	O
for	O
these	O
medications	O
and	O
your	O
heart	O
rate	O
improved.	O
While	O
you	O
were	O
here	O
you	O
had	O
ongoing	O
chest	O
pain.	O
We	O
thought	O
that	O
this	O
was	O
because	O
of	O
blocked	O
arteries	O
in	O
the	O
heart	O
(coronary	O
artery	O
disease)	O
preventing	O
oxygen	O
flow	O
to	O
the	O
heart.	O
You	O
were	O
taken	O
to	O
the	O
cardiac	O
catheterization	O
lab	O
on	O
___	O
where	O
two	O
stents	O
were	O
placed	O
to	O
your	O
right	O
coronary	O
artery.	O
We	O
hope	O
that	O
this	O
will	O
improve	O
your	O
chest	O
pain.	O
We	O
adjusted	O
some	O
of	O
your	O
medications	O
and	O
it	O
is	O
VERY	O
important	O
that	O
you	O
stop	O
taking	O
diltiazem	O
and	O
only	O
take	O
the	O
medications	O
on	O
the	O
new	O
list	O
we	O
give	O
you.	O
We	O
also	O
noticed	O
a	O
small	O
cut	O
under	O
your	O
right	O
big	O
toe	O
that	O
did	O
not	O
look	O
infected.	O
You	O
will	O
need	O
regular	O
wound	O
care.	O
We	O
made	O
an	O
appointment	O
for	O
podiatry	O
(foot	O
doctor)	O
follow	O
up.	O
It	O
is	O
important	O
to	O
go	O
to	O
this	O
appointment	O
and	O
check	O
your	O
blood	O
sugars	O
frequently.	O
Please	O
call	O
your	O
doctor	O
if	O
you	O
become	O
lightheaded	O
or	O
feel	O
like	O
you	O
are	O
going	O
to	O
lose	O
consciousness.	O
Followup	O
Instructions:	O
___	O

